Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4

CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME

v3.21.1
CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME - CAD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Profit or loss [abstract]    
Revenues $ 15,890 $ 9,074
Cost of revenues 7,081 4,761
Gross profit before fair value adjustments 8,809 4,313
Fair value adjustments:    
Unrealized change in fair value of biological assets 11,781 5,990
Realized fair value adjustments on inventory sold in the period (10,122) (6,374)
Total fair value adjustments 1,659 (384)
Gross profit after fair value adjustments 10,468 3,929
General and administrative expenses 11,413 6,422
Selling and marketing expenses 3,782 1,240
Research and development expenses 136 233
Listing cost of reverse acquisition   3,632
Share-based compensation 3,382 2,677
Total operating expenses 18,713 14,204
Operating loss (8,245) (10,275)
Finance income 277 3,653
Finance expenses (20,504) (707)
Finance income (expense), net (20,227) 2,946
Loss before income taxes (28,472) (7,329)
Income tax expense, net 262 90
Net Loss (28,734) (7,419)
Other comprehensive income (loss) that will not be reclassified to profit or loss in subsequent periods:    
Re-measurement loss on defined benefit plans (30) (29)
Exchange differences on translation to presentation currency 1,146 333
Total other comprehensive income that will not be reclassified to profit or loss in subsequent periods 1,116 304
Other comprehensive income that will be reclassified to profit or loss in subsequent periods:    
Adjustments arising from translating financial statements of foreign operation (124) (14)
Total other comprehensive income that will be reclassified to profit or loss in subsequent periods (124) (14)
Total other comprehensive income 990 290
Total comprehensive loss (27,744) (7,129)
Net income (loss) attributable to:    
Equity holders of the Company (28,698) (7,292)
Non-controlling interests (36) (127)
Net Loss (28,734) (7,419)
Total comprehensive income (loss) attributable to:    
Equity holders of the Company (27,806) (7,047)
Non-controlling interests 64 (82)
Total comprehensive loss $ (27,744) $ (7,129)
Net earnings (loss) per share attributable to equity holders of the Company    
Basic and diluted (in dollars per share) $ (0.74) $ (0.23)